News (Media Awareness Project) - UK: Web: Drug Users Fuel Hepatitis Boom |
Title: | UK: Web: Drug Users Fuel Hepatitis Boom |
Published On: | 1999-05-20 |
Source: | BBC News (UK Web) |
Fetched On: | 2008-09-06 06:06:01 |
DRUG USERS FUEL HEPATITIS BOOM
Drug users who inject are the main reason for a surge in the number of
cases of hepatitis B, public health officials have said.
Figures from the Public Health Laboratory Service (PHLS) show cases
have risen by almost a third since 1998 - up from 652 to 855.
Drug injecting was known to be the most likely cause in 46% of
infections.
Health officials have called for the government to invest in a
vaccination programme for drug users to prevent the disease spreading
out of control.
Liver disease
Hepatitis B can damage the liver, but it can also be carried for years
with no visible symptoms and it is usually expelled from the body
within 13 weeks of infection.
It is carried in body fluid and can be transmitted through sharing
needles, blood transplants and sex.
It is thought that around 50,000 people in the UK may carry the
virus.
Some will only go on to show flu-like symptoms, but in rare cases the
virus, if left untreated, can cause liver failure.
However the disease is 10 times more infectious than Aids, and the
PHLS fears that unless a vaccination programme is introduced,
incidence of the disease in the UK could grow to match that in the
Third World.
While in the UK less than a half a per cent of the population has the
disease, the incidence in India is between five and 10%.
Plea for vaccination
Dr Mary Ramsay, from the PHLS in London, said an effective vaccine
existed but was seldom given to injecting drug users.
"We've had very stable figures since the late 1980s, but a sharp
increase in the past two years," she said.
"What concerns us most is that this could be the start of a much
bigger increase. But it is a preventable disease, and there is
something we could do about it."
The Department of Health said part of the ?50m being given to health
authorities for drug services over the next three years was intended
to tackle hepatitis B.
A spokesman said: "We accept that injecting drug users are one of the
highest risk categories and for that reason they are a priority."
Drug users who inject are the main reason for a surge in the number of
cases of hepatitis B, public health officials have said.
Figures from the Public Health Laboratory Service (PHLS) show cases
have risen by almost a third since 1998 - up from 652 to 855.
Drug injecting was known to be the most likely cause in 46% of
infections.
Health officials have called for the government to invest in a
vaccination programme for drug users to prevent the disease spreading
out of control.
Liver disease
Hepatitis B can damage the liver, but it can also be carried for years
with no visible symptoms and it is usually expelled from the body
within 13 weeks of infection.
It is carried in body fluid and can be transmitted through sharing
needles, blood transplants and sex.
It is thought that around 50,000 people in the UK may carry the
virus.
Some will only go on to show flu-like symptoms, but in rare cases the
virus, if left untreated, can cause liver failure.
However the disease is 10 times more infectious than Aids, and the
PHLS fears that unless a vaccination programme is introduced,
incidence of the disease in the UK could grow to match that in the
Third World.
While in the UK less than a half a per cent of the population has the
disease, the incidence in India is between five and 10%.
Plea for vaccination
Dr Mary Ramsay, from the PHLS in London, said an effective vaccine
existed but was seldom given to injecting drug users.
"We've had very stable figures since the late 1980s, but a sharp
increase in the past two years," she said.
"What concerns us most is that this could be the start of a much
bigger increase. But it is a preventable disease, and there is
something we could do about it."
The Department of Health said part of the ?50m being given to health
authorities for drug services over the next three years was intended
to tackle hepatitis B.
A spokesman said: "We accept that injecting drug users are one of the
highest risk categories and for that reason they are a priority."
Member Comments |
No member comments available...